Income Statement
BIOATLA, INC.
BCAB
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
61.31 | 84.94 | 129.69 | 108.14 | 96.69 |
|
Research & Development
|
43.57 | 63.10 | 103.73 | 79.35 | 58.27 |
|
Selling, General & Administrative
|
17.73 | 21.85 | 25.96 | 28.79 | 38.42 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-61.31 | -84.94 | -129.69 | -108.14 | -96.69 |
|
Non-Operating Income
|
- | - | - | - | - |
|
Interest Income
|
0.84 | 3.37 | 6.31 | 1.65 | 0.35 |
|
Interest Expense
|
- | - | - | 0.00 | 0.00 |
|
Other Non-Op Income / Expense
|
-0.30 | 4.17 | 6.23 | 1.66 | 1.04 |
|
Income Before Tax
|
- | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | 0.00 |
|
Net Income
|
-59.61 | -69.78 | -123.46 | -106.48 | -95.40 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-60.93 | -84.02 | -128.47 | -106.94 | -95.36 |
|
Earnings Per Share (Basic)
|
-1.01 | -1.44 | -2.58 | -2.74 | - |
|
Diluted EPS
|
-1.01 | -1.44 | -2.58 | -2.74 | - |
|
Weighted Average Shares
|
58.83 | 48.57 | 47.78 | 38.93 | - |
|
Diluted Weighted Avg Shares
|
58.83 | 48.57 | 47.78 | 38.93 | - |
|
Comprehensive Income
|
- | - | - | - | - |